Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
886,6 DKK | +2,28% | +2,36% | +27,00% |
25/04 | NOVO NORDISK : JP Morgan herhaalt koopadvies | ZD |
25/04 | Scholz belooft steun voor farmaceutische sector in Duitsland nu Merck investeert | RE |
ETF's gepositioneerd op Novo Nordisk A/S
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
21.31% | 192 M€ | +13,43% | ||
10.45% | 5 M€ | +8,63% | ||
5.40% | 18 M€ | +3,79% | - | |
4.67% | 88 M€ | +10,37% | - | |
3.95% | 4 M€ | -.--% | - | |
3.91% | 5 M€ | +10,09% | - | |
3.91% | 14 M€ | +5,66% | - | |
3.78% | 6 M€ | -.--% | ||
3.09% | 12 M€ | +15,09% | - | |
3.02% | 6 M€ | -.--% | - | |
2.87% | 29 M€ | +8,37% | - | |
2.53% | 3 859 M€ | +18,82% | - | |
2.53% | 469 M€ | -2,05% | - | |
2.22% | 3 M€ | +9,95% | - | |
1.91% | 2 M€ | -.--% | - | |
1.91% | 2 M€ | +9,19% | - | |
1.67% | 10 M€ | -3,35% | - | |
1.60% | 10 M€ | +6,14% | - | |
1.31% | 267 M€ | +5,99% | ||
1.30% | 49 M€ | +5,28% | ||
1.04% | 276 M€ | +11,40% | - | |
1.03% | 7 M€ | +1,95% | - | |
0.89% | 1 120 M€ | +0,40% | ||
0.79% | 284 M€ | -.--% | ||
0.76% | 786 M€ | -.--% | ||
0.76% | 23 M€ | -.--% | - | |
0.75% | 206 M€ | -.--% | ||
0.70% | 7 M€ | +0,11% | - | |
0.64% | 277 M€ | -.--% | - | |
0.64% | 194 M€ | +5,65% | - | |
0.64% | 441 M€ | +10,26% | ||
0.57% | 717 M€ | +6,20% |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+27,00% | 556 mld. | |
+25,83% | 653 mld. | |
-6,76% | 354 mld. | |
+20,34% | 331 mld. | |
+3,00% | 296 mld. | |
+13,09% | 233 mld. | |
+5,46% | 201 mld. | |
-9,61% | 193 mld. | |
-6,26% | 144 mld. | |
-11,77% | 143 mld. |
- Beurs
- Aandelen
- Koers NOVO B
- ETF's Novo Nordisk A/S